1102Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction
Roy, C, Slimani, A, De Meester, C, Amzulescu, M, Ferracin, B, Ginion, A, Pasquet, A, Vancraeynest, D, Vanoverschelde, J.-L, Gerber, B, Beauloye, C, Horman, S, Gruson, D, Pouleur, A.-C
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
1101Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction
Roy, C, Slimani, A, De Meester, C, Amzulescu, M, Ferracin, B, Ginion, A, Pasquet, A, Vancraeynest, D, Vanoverschelde, J.-L, Gerber, B, Beauloye, C, Horman, S, Gruson, D, Pouleur, A.-C
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
Elevated suppression of tumorigenicity 2 receptor is associated with poor outcome in heart failure with preserved ejection fraction
Roy, C., Slimani, A., De Meester, C., Amzulescu, M., Ferracin, B., Ginion, A., Pasquet, A., Vancraeynest, D., Vanoverschelde, J.L., Gerber, B., Beauloye, C., Horman, S., Gruson, D., Pouleur, A.C.
Published in Archives of Cardiovascular Diseases Supplements (01.04.2018)
Published in Archives of Cardiovascular Diseases Supplements (01.04.2018)
Get full text
Journal Article
P202: Rôle de l’IGF-I et de l’Insuline dans l’hypertrophie musculaire induite par la Follistatine
Barbé, C., Kalista, S., Lause, P., Ferracin, B., Thissen, J.-P.
Published in Nutrition clinique et métabolisme (01.12.2014)
Published in Nutrition clinique et métabolisme (01.12.2014)
Get full text
Journal Article